Publications 2010 – 2014

111. Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N. Clin Cancer Res; 15(18): 5829-39. PDF
110. Sornay-Rendu E, Boutroy S, Munoz F, Bouxsein ML. Cortical and trabecular architecture are altered in postmenopausal women with fractures. Osteop Int 2009; 20(8): 1291-97. PDF
109. Bouxsein M, Chen P, Glass E, Kallmes D, Delmas P, Mitlak B. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis: Results from two randomized, controlled trials. J Bone Jt Surg (Am) 2009; 91(6): 1321-28. PDF
108. Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML. Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am 2009; 34(4): 595-602. PDF
107. Yakar S, Canalis E, Sun H, Mejia W, Kawashima Y, Nasser P, Courtland HW, Williams V, Bouxsein M, Rosen C, Jepsen KJ. Serum IFG-1 determines skeletal strength by regulating sub-periosteal expansion and trait interactions. J Bone Min Res 2009; 24(8): 1481-92. PDF
106. Kirmani S, Christen D, van Lenthe GH, Fischer PR, Bouxsein ML, McCready LK, Melton LJ, Riggs BL, Amin S, Muller R, Khosla S. Bone structure at the distal radius during adolescent growth. J Bone Min Res 2009; 24(6):1033-42. PDF
105. Brouwers JEM, Ruchelsman M, van Rietbergen B, Bouxsein ML. Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic acid treated, ovariectomized rats. Osteop Int 2009; 20(8):1377-84. PDF
104. Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, Rucci N, Cavat F, Rizzoli R, Teti A, Bouxsein ML, Ferrari SL. Beta-arrestin2 regulates RANKL and Ephrins gene expression in response to bone remodeling in mice. J Bone Min Res 2009; 24(5); 775-84. PDF
103. Nielson CM, Bouxsein ML, Freitas SS, Ensrud KE, Orwoll ES; for the Osteoporotic Fractures in Men (MrOS) Research Group. Trochanteric soft tissue thickness and hip fracture in older men. J Clin Endocrinol Metab 2009; 94(2): 491-6. PDF
102. Yakar S, Rosen CJ, Bouxsein ML, Sun H, Mejia W, Kawashima Y, Wu Y, Emerton K, Williams V, Jepsen K, Schaffler MB, Majeska RJ, Gavrilova O, Gutierrez M, Hwang D, Pennisi P, Frystyk J, Boisclair Y, Pintar J, Jasper H, Domene H, Cohen P, Clemmons D, Leroith D. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J 2009; 23(3):709-19. PDF
101. Fajardo RJ, Cory E, Patel ND, Nazarian A, Laib A, Manoharan RK, Schmitz JE, Desilva JM, Maclatchy LM, Snyder BD, Bouxsein ML. Specimen size and porosity can introduce error into μCT-based tissue mineral density measurements. Bone 2009; 44(1):176-84 PDF
100. Bouxsein ML, Devlin MD, Glatt V, Dhillon H, Pierroz DP, Ferrari SL. Mice lacking β-adrenergic receptors have increased bone mass, but are not protected from deleterious skeletal effects of ovariectomy. Endocrinology 2009. 150(1): 144-52. PDF
99. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Fukuda T, Mishina Y, Peterson RT, Block KD. BMP Type I receptor inhibition prevents ectopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Nature Med 2008; Dec14(12):1363-9.
98. Okazaki M, Ferrandon S, Vilardaga JP, Bouxsein ML, Potts JT Jr, Gardella TJ. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A. 2008; 105(43):16525-30.
97. Melton LJ 3rd, Riggs BL, Leibson CL, Achenbach SJ, Camp JJ, Bouxsein ML, Atkinson EJ, Robb RA, Khosla S. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 2008; 93(12): 4804-9
96. Brouwers JEM, Ruchelsman R, van Rietbergen B, Bouxsein ML. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats. Calcified Tissue Int 2008; Sep;83(3):186-91.
95. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC, Fonhoue BD, Caron A, Bronson R, Bouxsein ML, Mukherjee S, Lees JA. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11851-6.
94. Arlot M, Burt-Pichat B, Roux J, Vashisht D, Bouxsein M, Delmas PD. Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Min Res 2008; 23(10):1613-8.
93. Ackert-Bicknell CL, Demissie S, de Evsikova CM, Hsu YH, Demambro VE, Karasik D, Cupples LA, Ordovas JM, Tucker KL, Cho K, Canalis E, Paigen B, Churchill GA, Forejt J, Beamer WG, Ferrari S, Bouxsein ML, Kiel DP, Rosen CJ. A PPARG by dietary fat interaction influences bone mass in mice and humans. J Bone Min Res 2008; 23(9):1398-408.
92. Keaveny TM and Bouxsein ML. Theoretical implications of the biomechanical fracture threshold. J Bone Min Res 2008; 23(10):1541-7.
91. O’Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling A, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One 2008 Aug 13; 3 (8) e2942.
90. Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using quantitative computed tomography. J Bone Min Res; 2008; 23 (8): 1326-33.
89. Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer PB. Comparison of skeletal effects of ovariectomy versus chemically-induced ovarian failure in mice. J Bone Min Res 2008; 23 (8):1296-1303.
88. Bouxsein ML and Delmas PD. Considerations for development of surrogate endpoints for anti-fracture efficacy of new treatments in osteoporosis: a perspective. J Bone Min Res 2008; 23 (8): 1155-67.
87. Davey RA, Turner AG, McManus JF, Chiu WSM, Tjahyono F, Moore AJ, Atkins GJ, Anderson PH, Ma C, Glatt V, MacLean HE, Vincent C, Bouxsein M, Morris HA, Findlay DM, Zajac JD. Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Min Res 2008; 23 (8); 1182-93.
86. Shimada M, Greer PA, McMahon AP, Bouxsein ML, Schipani E. In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation. 2008; J Biol Chem 2008; 283 (30): 21002-10.
85. Pearsall RA, Canalis E, Corwall-Brady M, Underwood KW, Haigis B, Ucran J, Kumar R, Pobre E, Brinberg A, Werner ED, Glatt V, Stadmeyer L, Smith D, Seehra J, Bouxsein ML. A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci USA 2008; 105 (19): 7082-7.
84. Rosental TD, Makhni EC, Day CS, Bouxsein ML. Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 2008; 90 (5): 953-61.
83. DeMambro VE, Clemmons Dr, Horton LG, Bouxsein ML, Wood TL, Beamer WG, Canalis E, Rosen CJ. Gender-specific changes in bone turnover and skeletal architecture in ifgbp-2 null mice. Endocrinology 2008; 149(5): 2051-61.
82. Black DM, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling. J Clin Endocrinol Metab 2008; 93 (6): 2166-72.
81. McManus JF, Davey RA, Maclean HE, Doust EA, Chia WS, Sims NA, Bouxsein ML, Glatt V, Zajac JD, Danks JA. Intermittent Fugu parthyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats. Bone 2008; 42 (6): 1164-74.
80. Mukherjee S, Raje N, Schoonmaker JA, Liu JC, Hideshima T, Wein MN, Jones DC, Vallet S, Bouxsein ML, Pozzi S, Chhetri S, Seo YD, Aronson JP, Patel C, Fulciniti M, Purton LE, Glimcher LH, Lian JB, Stein G, Anderson KC, Scadden DT. Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Inv 2008; 118 (2): 491-504.
79. Boutroy S, van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Min Res 2008; 23 (3): 392-99.
78. Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Vrahas MS, Bouxsein ML, Evans CH. Delayed administration of adenoviral BMP-2 improves the formation of bone in osseous defects. Gene Ther 2007; 14 (13): 1039-44.
77. Betz VM, Betz OB, Glatt V, Gerstenfeld LC, Einhorn TA, Bouxsein ML, Vrahas MS, Evans CH. Healing of segmental bone defects by direct percutaneous gene delivery: Effect of vector dose. Hum Gene Ther 2007; 18 (10): 907-15.
76. Melton LJ, Riggs BL, Keaveny TM, Achenbach SJ, Hoffman PF, Camp JJ, Rouleau PA, Bouxsein ML, Amin S, Atkinson EJ, Robb RA, Khosla S. Structural determinants of vertebral fracture risk. J Bone Min Res 2007, 22 (12): 1885-92.
75. Kostenuik P, Ferrari S, Pierroz D, Bouxsein M, Morony S, Warmington KS, Adamu S, Geng Z, Grisanti M, Shalhoub V, Martin S, Biddlecome G, Shimamoto G, Boone T, Shen V.Lacey D. Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone. J Bone Min Res 2007; 22 (10): 1534-47.
74. Melton LJ, Riggs BL, van Lenthe GH, Achenbach SJ, Muller R, Bouxsein ML, Amin S, Atkinson EJ, Khosla S. Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Min Res 2007; 22(9): 1442-8.
73. Tsiridis E, Morgan EF, Bancroft JM, Song M, Kain M, Gerstenfeld L, Einhorn TA, Bouxsein ML, Tornetta P. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. J Orthop Res 2007; 25 (9): 1193-1203.
72. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Min Res 2007; 22 (8): 1197-1207.
71. Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Verhas MS, Bouxsein ML, Evans CH. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 2007; 14 (13): 1039-44.
70. Wang Y, Wan C, Liu X, Cao X, Bouxsein ML, Faugere M-C, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL (2007) The hypoxia-inducible factor pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117(6):1616-26.
69. Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay-Rendu E, Delmas PD. Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture. J Bone Min Res 2007: 22(6): 25-31.
68. Yang D, Singh R, Divieti P, Guo J, Bouxsein ML, Bringhurst FR. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone 2007; 40 (6): 1453-61.
67. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere M-C, Bouxsein ML, Wan C, Williams BO, Clemens TL. Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci 2007; 104 (7): 2259-64.
66. Notini A, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WM, Glatt V, Kream BE, Handelsman DJ, Morris H, Zajac JD, Davey RA. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Min Res 2007; 22 (3): 347-56.
65. Hsu YH, Xu X, Terwedow HA, Niu T, Hung X, Wu D, Wang L, Brain JD, Bouxsein ML, Cummings SR, Rosen CJ. A large-scale genome-wide linkage analysis for loci linked to bone mineral density at different skeletal sites in extreme selected sibships. J Bone Min Res 2007; 22 (2): 184-194.
64. Zalloua PA, Hsu YH, Terwedo H, Zang T, Wu D, Tang G, Li Z, Hong X, Azar ST, Wang B, Bouxsein ML, Brain J, Cummings SR, Rosen CJ, Xu X. Impact of seafood and fruit consumption on bone mineral density. Maturitas 2007; 56 (1): 1-11.
63. Bouxsein ML, Riggs BL, Melton LJ III, Muller JA, Atkinson EJ, Oberg A, Robb RA, Camp JJ, Rouleau PA, McCollough CH, Khosla S. Biomechanical assessment of the age- and sex-related differences vertebral fragility: A population-based study using QCT. J Bone Min Res 2006; 21 (9): 1475-82.
62. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming J, Byrjalsen I, Delmas PD, Bouxsein ML. Contribution of the advanced glycation endproduct pentosidine and maturation of the collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 2006; 39 (5): 1073-9.
61. Pierroz DP, Bouxsein ML, Rizzoli R, Ferrari SL. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 2006; 39 (2): 260-7.
60. Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclair Y, Leroith D, Rosen CJ. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. Journal of Endocrinol 2006; 189 (2): 289-99.
59. Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 2006; 38: 300-9.
58. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans, CH. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg (Am) 2006; 88:355-65.
57. Hsu YH, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, Laird N, Brain JD, Cummings SR, Bouxsein ML, Rosen CJ, Xu X. Relationship of body composition, fat mass and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83: 146-54.
56. Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, Oberg A, Rouleau PA, McCollough CH, Khosla S, Bouxsein ML. Population based analysis of the relationship of whole bone strength indices and fall-related loads to age- and sex-specific patterns of hip and wrist fractures. J Bone Min Res 2006; 21:315-23.
55. Seeherman H, Li R, Bouxsein M, Kim H, Li XJ, Smith-Adaline E, Aiolova M, Wozney JM. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a non-human primate model at multiple treatment times and concentrations. J Bone Jt Surg (Am) 2006; 88: 144-160.
54. Feng Y, Hsu YH, Terwedow H, Chen C, Xu X, Niu T, Zang T, Wu D, Tang G, Li Z, Hong X, Wang B, Brain JD, Cummings SR, Rosen C, Bouxsein ML, Xu X. Familial aggregation of bone mineral density and bone mineral content in a Chinese population. Osteop Int 2005: 16 (12): 1917-23.
53. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrin & Metab 2005; 90 (12): 6508-15.
52. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO. Essential role of beta-catenin in post-natal bone acquisition. J Biol Chem 2005; 280 (22): 21162-8.
51. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WJ. Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Min Res 2005; 20 (7): 1085-92.
50. Knopp E, Troiano N, Bouxsein M, Sun BH, Lostritto K, Gundberg C, Dziura J, Insogna K. The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone. Endocrinology 2005; 146: 1983-1990.
49. Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, Bouxsein ML. Bone response to intermittent parathyroid hormone is altered in mice null for ß-arrestin2. Endocrinology 2005; 146:1854-1862.
48. Bouxsein ML, Pierroz D, Glatt V, Goddard DS, Cavat F, Rizzoli R, Ferrari SL. Beta-arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J Bone Min Res, 2005; 20:635-43.
47. Rosen CJ, Ackert-Bicknell C, Beamer WG, Nelson T, Adamo M, Cohen P, Bouxsein ML, Horowitz MC. Allelic differences in quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition. Pediatr Nephrol, 2005; 20:255-260.